Integrative Organelle-Based Functional Proteomics: In Silico Prediction of Impaired Functional Annotations in SACS KO Cell Model
- PMID: 35892334
- PMCID: PMC9331974
- DOI: 10.3390/biom12081024
Integrative Organelle-Based Functional Proteomics: In Silico Prediction of Impaired Functional Annotations in SACS KO Cell Model
Abstract
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is an inherited neurodegenerative disease characterized by early-onset spasticity in the lower limbs, axonal-demyelinating sensorimotor peripheral neuropathy, and cerebellar ataxia. Our understanding of ARSACS (genetic basis, protein function, and disease mechanisms) remains partial. The integrative use of organelle-based quantitative proteomics and whole-genome analysis proposed in the present study allowed identifying the affected disease-specific pathways, upstream regulators, and biological functions related to ARSACS, which exemplify a rationale for the development of improved early diagnostic strategies and alternative treatment options in this rare condition that currently lacks a cure. Our integrated results strengthen the evidence for disease-specific defects related to bioenergetics and protein quality control systems and reinforce the role of dysregulated cytoskeletal organization in the pathogenesis of ARSACS.
Keywords: ARSACS; KO models; SACS; biomarkers; lysosomes; mitochondria; omics.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Engert J.C., Bérubé P., Mercier J., Doré C., Lepage P., Ge B., Bouchard J.-P., Mathieu J., Melançon S.B., Schalling M., et al. ARSACS, a spastic ataxia common in northeastern Québec, is caused by mutations in a new gene encoding an 11.5-kb ORF. Nat. Genet. 2000;24:120–125. doi: 10.1038/72769. - DOI - PubMed
-
- Romano A., Tessa A., Barca A., Fattori F., de Leva M.F., Terracciano A., Storelli C., Santorelli F.M., Verri T. Comparative analysis and functional mapping of SACS mutations reveal novel insights into sacsin repeated architecture. Hum. Mutat. 2013;34:525–537. doi: 10.1002/humu.22269. - DOI - PMC - PubMed
-
- Girard M., Lariviere R., Parfitt D.A., Deane E.C., Gaudet R., Nossova N., Blondeau F., Prenosil G., Vermeulen E.G.M., Duchen M.R., et al. Mitochondrial dysfunction and Purkinje cell loss in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) Proc. Natl. Acad. Sci. USA. 2012;109:1661–1666. doi: 10.1073/pnas.1113166109. - DOI - PMC - PubMed
-
- Criscuolo C., Procaccini C., Meschini M.C., Cianflone A., Carbone R., Doccini S., Devos D., Nesti C., Vuillaume I., Pellegrino M., et al. Powerhouse failure and oxidative damage in autosomal recessive spastic ataxia of Charlevoix-Saguenay. J. Neurol. 2015;262:2755–2763. doi: 10.1007/s00415-015-7911-4. - DOI - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Research Materials
